Interleukin 1 Type 1 Receptor Restore: a Genetic Mouse Model for Studying Interleukin 1 Receptor-mediated Effects in Specific Cell Types
Overview
Authors
Affiliations
Interleukin-1 (IL-1) mediates diverse neurophysiological and neuropathological effects in the CNS through type I IL-1 receptor (IL-1R1). However, identification of IL-1R1-expressing cell types and cell-type-specific functions of IL-1R1 remains challenging. In this study, we created a novel genetic mouse model in which IL-1R1 gene expression is disrupted by an intronic insertion of a loxP flanked disruptive sequence that can be deleted by Cre recombinase, resulting in restored IL-1R1 gene expression under its endogenous promoters. A second mutation was introduced at stop codon of the IL-1R1 gene to allow tracking of the restored IL-1R1 protein by a 3HA tag and IL-1R1 mRNA by tdTomato fluorescence. These animals were designated as IL-1R1(r/r) and exhibited an IL-1R1 knock-out phenotype. We used IL-1R1 globally restored mice (IL-1R1(GR/GR)) as an IL-1R1 reporter and observed concordant labeling of IL-1R1 mRNA and protein in brain endothelial cells. Two cell-type-specific IL-1R1 restore lines were generated: Tie2Cre-IL-1R1(r/r) and LysMCre-IL-1R1(r/r). Brain endothelial COX-2 expression, CNS leukocyte infiltration, and global microglia activation induced by intracerebroventricular injection of IL-1β were not observed in IL-1R1(r/r) or LysMCre-IL-1R1(r/r) mice, but were restored in Tie2Cre-IL-1R1(r/r) mice. These results reveal IL-1R1 expression in endothelial cells alone is sufficient to mediate these central IL-1-induced responses. In addition, ex vivo IL-1β stimulation increased IL-1β expression in bone marrow cells in wild-type, Tie2Cre-IL-1R1(r/r), and LysMCre-IL-1R1(r/r), but not IL-1R1(r/r) mice. These results demonstrate this IL-1R1 restore model is a valuable tool for studying cell-type-specific functions of IL-1R1.
Packer J, Giammo S, Wangler L, Davis A, Bray C, Godbout J Res Sq. 2025; .
PMID: 40034431 PMC: 11875282. DOI: 10.21203/rs.3.rs-5960640/v1.
Nemeth D, Liu X, Monet M, Niu H, Maxey G, Schrier M J Neuroinflammation. 2024; 21(1):303.
PMID: 39563437 PMC: 11575132. DOI: 10.1186/s12974-024-03287-1.
Mao Y, Yang Q, Liu J, Fu Y, Zhou S, Liu J Oxid Med Cell Longev. 2024; 2024:5632260.
PMID: 39139212 PMC: 11321896. DOI: 10.1155/2024/5632260.
Jiang L, Ye C, Huang Y, Hu Z, Wei G Acta Biochim Biophys Sin (Shanghai). 2024; 56(5):789-804.
PMID: 38686458 PMC: 11187487. DOI: 10.3724/abbs.2024035.
Goodman E, Biltz R, Packer J, DiSabato D, Swanson S, Oliver B Mol Psychiatry. 2024; 29(8):2321-2334.
PMID: 38459193 PMC: 11412902. DOI: 10.1038/s41380-024-02456-1.